In the news

Coming out of the economic shutdown caused by the pandemic, health systems are engaged in “purposeful restarts” in which deliberate decisions are being made about whether and where specific clinical programs re-emerge. Drawing a parallel to an iconic landmark in the English countryside, VRI's Tom Robertson considers the role of inertia, both in nature and within complex organizations.

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.

Stakeholders Weigh In on the Key Biosimilar Developments of 2018

The Center for Biosimilars

ASC supply chain tip of the day: Find product alternatives

Becker's ASC Review

Hospitals still use paper to send, receive summary of care records

Health Data Management

Why The U.S. Remains The World's Most Expensive Market For 'Biologic' Drugs

Kaiser Health News

NYC launches 1st city-led nurse residency program in the US

Becker's Clinical Leadership & Infection Control

ASC supply chain tip of the day: Measure metrics

Becker's ASC Review

Women Leaders in Supply Chain

The Journal of Healthcare Contracting

What Biosimilar Metamorphoses Are In Store For 2019?

Biosimilar Development

Doctors: If you aren't part of the opioid crisis solution, you're part of the problem

US News and World Report

Observation Deck 2018

Journal of Healthcare Contracting

Featured content

Stonehenge and Health System Mergers: The Role of Inertia